Literature DB >> 31450448

Dried blood spot N-glycome analysis by MALDI mass spectrometry.

Gerda C M Vreeker1, Marco R Bladergroen2, Simone Nicolardi3, Wilma E Mesker4, Rob A E M Tollenaar4, Yuri E M van der Burgt5, Manfred Wuhrer2.   

Abstract

Body fluid N-glycome analysis as well as glyco-proteoform profiling of existing protein biomarkers potentially provides a stratification layer additional to quantitative, diagnostic protein levels. For clinical omics applications, the collection of a dried blood spot (DBS) is increasingly pursued as an alternative to sampling milliliters of peripheral blood. Here we evaluate DBS cards as a blood collection strategy for protein N-glycosylation analysis aiming for high-throughput clinical applications. A protocol for facile N-glycosylation profiling from DBS is developed that includes sialic acid linkage differentiation. This protocol is based on a previously established total plasma N-glycome mass spectrometry (MS) method, with adjustments for the analysis of DBS specimens. After DBS-punching and protein solubilization N-glycans are released, followed by chemical derivatization of sialic acids and MS-measurement of N-glycan profiles. With this method, more than 80 different glycan structures are identified from a DBS, with RSDs below 10% for the ten most abundant glycans. N-glycan profiles of finger-tip blood and venous blood are compared and short-term stability of DBS is demonstrated. This method for fast N-glycosylation profiling of DBS provides a minimally invasive alternative to conventional serum and plasma protein N-glycosylation workflows. With simplified blood sampling this DBS approach has vast potential for clinical glycomics applications.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dried blood spot; Glycosylation profiling; MALDI-FTICR-MS; MALDI-TOF-MS; Released N-glycans

Year:  2019        PMID: 31450448     DOI: 10.1016/j.talanta.2019.06.104

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  5 in total

Review 1.  Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells.

Authors:  Calvin R K Blaschke; Colin T McDowell; Alyson P Black; Anand S Mehta; Peggi M Angel; Richard R Drake
Journal:  Clin Lab Med       Date:  2021-04-24       Impact factor: 2.172

2.  Immunoglobulin G Glycoprofiles are Unaffected by Common Bottom-Up Sample Processing.

Authors:  Manuela Amez-Martín; Manfred Wuhrer; David Falck
Journal:  J Proteome Res       Date:  2020-09-18       Impact factor: 4.466

3.  Comparison of self-sampling blood collection for N-glycosylation analysis.

Authors:  Ana Cvetko; Marko Tijardović; Iva Bilandžija-Kuš; Olga Gornik
Journal:  BMC Res Notes       Date:  2022-02-16

4.  Qualitative and quantitative detection of SARS-CoV-2 antibodies from dried blood spots.

Authors:  Catherine L Omosule; Justin Conklin; Sohkna Seck; Renée Howell; Karl G Hock; Claire Ballman; James Freeman; Leon Du Toit; Erik Dubberke; Christopher W Farnsworth
Journal:  Clin Biochem       Date:  2022-01-03       Impact factor: 3.281

5.  MALDI-2 for the Enhanced Analysis of N-Linked Glycans by Mass Spectrometry Imaging.

Authors:  Bram Heijs; Alexander Potthoff; Jens Soltwisch; Klaus Dreisewerd
Journal:  Anal Chem       Date:  2020-10-07       Impact factor: 6.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.